UCSF 42nd Annual Advances in Heart Disease 2025

Introduction

The UCSF 42nd Annual Advances in Heart Disease 2025 is a comprehensive cardiovascular medicine educational program designed to provide clinicians with practical updates in the diagnosis, prevention, and management of contemporary cardiovascular disease. Developed by UCSF Health, this longstanding annual course brings together cardiovascular experts to review evolving clinical guidelines, interventional strategies, arrhythmia management approaches, heart failure therapies, preventive cardiology, and emerging evidence shaping modern cardiac care.

Focused on clinically relevant and practice-oriented education, the course explores a broad spectrum of cardiovascular topics including coronary artery disease, atrial fibrillation, thromboembolic disorders, hypertension, lipid management, valvular heart disease, percutaneous coronary intervention, heart failure, and cardiovascular risk reduction. The curriculum also highlights the growing importance of social determinants of health and their impact on cardiovascular outcomes and treatment access.

Designed for specialists and frontline clinicians caring for patients with cardiovascular disease, the program integrates guideline-focused instruction with practical decision-making strategies to support improved patient outcomes across outpatient, inpatient, and procedural cardiovascular settings.

Files Included

The UCSF 42nd Annual Advances in Heart Disease 2025 educational package includes advanced cardiovascular medicine learning resources.

Included resources may include:

• Cardiovascular medicine lectures
• Clinical cardiology presentations
• Guideline-focused educational sessions
• Interventional cardiology discussions
• Heart failure and arrhythmia management updates
• Preventive cardiology reviews
• Valvular heart disease education
• Thromboembolic disease management sessions

Additional highlights:

• Comprehensive cardiovascular update curriculum
• Multidisciplinary cardiology education
• Practice-focused clinical teaching
• Evidence-informed cardiovascular management discussions

These resources support continuing medical education in cardiology, preventive cardiovascular medicine, arrhythmia management, interventional cardiology, and advanced cardiovascular therapeutics.

Why This Course Is Important

Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, while treatment strategies continue to evolve rapidly through advances in interventional cardiology, electrophysiology, heart failure therapeutics, antithrombotic management, structural heart interventions, and preventive cardiovascular medicine.

Clinicians managing cardiovascular patients must stay current with changing guidelines, emerging pharmacologic therapies, procedural innovations, and increasingly personalized approaches to cardiovascular risk assessment and treatment planning. At the same time, growing awareness of healthcare disparities and social determinants of health has highlighted the need for more equitable cardiovascular care delivery.

The UCSF 42nd Annual Advances in Heart Disease 2025 addresses these challenges through a broad and clinically practical curriculum focused on contemporary cardiovascular management, procedural decision-making, risk reduction strategies, and multidisciplinary patient care.

What Participants Will Learn

Participants completing this course will strengthen their expertise in modern cardiovascular disease management and preventive cardiology.

Learning objectives include:

• Optimizing management of coronary heart disease
• Applying current hypertension and lipid disorder treatment strategies
• Managing systolic and diastolic heart failure
• Improving treatment approaches for atrial fibrillation and atrial flutter
• Refining ventricular tachycardia ablation considerations
• Applying best practices in percutaneous coronary intervention
• Improving antiplatelet and anticoagulation management strategies
• Recognizing cardiovascular risk stratification principles
• Understanding percutaneous treatment options for valvular heart disease
• Addressing social determinants of health affecting cardiovascular outcomes

The curriculum integrates clinical cardiology, electrophysiology, interventional cardiology, preventive medicine, structural heart disease, and cardiovascular pharmacology into a clinically practical educational experience.

Full Course Topics & Lectures

Coronary Artery Disease & Preventive Cardiology

Coronary Heart Disease Management

Risk Stratification in Cardiovascular Disease

Lipid Disorder Treatment Strategies

Hypertension Management

Preventive Cardiovascular Medicine

Heart Failure & Cardiomyopathy

Systolic Heart Failure

Diastolic Heart Failure

Contemporary Heart Failure Therapies

Cardiometabolic Considerations in Heart Failure

Arrhythmias & Electrophysiology

Atrial Fibrillation Management

Atrial Flutter Ablation Considerations

Ventricular Tachycardia Ablation

Antiarrhythmic Therapy Strategies

Electrophysiology Decision-Making

Interventional Cardiology

Percutaneous Coronary Intervention

Coronary Revascularization Strategies

Structural Heart Interventions

Procedural Cardiovascular Care

Valvular & Structural Heart Disease

Percutaneous Treatment of Valvular Heart Disease

Structural Heart Disease Management

Catheter-Based Valve Therapies

Advanced Valvular Intervention Considerations

Thromboembolic Disease & Antithrombotic Therapy

Thromboembolic Disease Management

Antiplatelet Therapy Optimization

Anticoagulation Strategies in Cardiovascular Disease

Prevention of Cardiovascular Thrombotic Events

Diabetes & Cardiovascular Disease

Cardiovascular Risk in Diabetes

Integrated Cardiometabolic Management

Preventive Approaches in Diabetes-Associated Cardiovascular Disease

Social Determinants & Population Cardiovascular Health

Social Determinants of Health in Cardiology

Health Equity in Cardiovascular Care

Strategies to Improve Cardiovascular Outcomes

Reducing Cardiovascular Care Disparities

Educational Experience & Learning Features

The UCSF 42nd Annual Advances in Heart Disease 2025 combines practical cardiovascular education with contemporary guideline and therapeutic updates.

Educational features include:

• Expert-led cardiovascular medicine lectures
• Guideline-focused cardiology updates
• Interventional cardiology discussions
• Arrhythmia and electrophysiology education
• Preventive cardiology reviews
• Heart failure management updates
• Structural heart disease teaching
• Multidisciplinary cardiovascular care discussions
• Risk stratification and pharmacology education
• Clinically practical cardiovascular decision-making strategies

The curriculum integrates preventive cardiology, interventional cardiology, electrophysiology, heart failure medicine, vascular risk reduction, and structural heart disease into a comprehensive educational platform.

Who Should Take This Course

The UCSF 42nd Annual Advances in Heart Disease 2025 is intended for clinicians involved in cardiovascular diagnosis, treatment, prevention, and long-term cardiac care.

This course is especially valuable for:

• Cardiovascular specialists
• Practicing cardiologists
• Internists
• Family physicians
• Cardiovascular nurses
• Critical care nurses
• Physician assistants
• Advanced cardiovascular practitioners
• Clinicians managing complex cardiovascular disease

The curriculum is particularly relevant for clinicians seeking updated expertise in cardiovascular guidelines, interventional therapies, arrhythmia management, and preventive cardiology.

Clinical Applications & Practice Benefits

The course provides clinically practical cardiovascular education focused on improving patient outcomes, procedural decision-making, and preventive care strategies.

Participants gain practical insight into:

• Coronary artery disease management
• Heart failure treatment optimization
• Arrhythmia and ablation decision-making
• Percutaneous intervention strategies
• Anticoagulation and antiplatelet therapy management
• Cardiovascular risk assessment
• Valvular heart disease intervention planning
• Diabetes-related cardiovascular risk reduction
• Evidence-informed cardiovascular pharmacology
• Health equity and population cardiovascular care strategies

The educational content strengthens clinical confidence while supporting improved cardiovascular outcomes across diverse patient populations.

Professional Summary

The UCSF 42nd Annual Advances in Heart Disease 2025 from UCSF Health provides a comprehensive and clinically practical review of contemporary cardiovascular medicine, preventive cardiology, arrhythmia management, heart failure care, and interventional treatment strategies.

Through expert-led educational sessions and multidisciplinary cardiovascular discussions, the curriculum explores coronary artery disease, hypertension, lipid disorders, atrial fibrillation, thromboembolic disease, valvular interventions, heart failure therapies, and social determinants of cardiovascular health.

Its combination of guideline-focused education, procedural cardiology updates, preventive care strategies, and practical patient management makes this course a valuable educational resource for cardiologists, internists, advanced practice clinicians, and healthcare professionals seeking advanced expertise in modern cardiovascular medicine.